CEOArthur Costa
BS Chemical Biology, UChicago ’27Chemistry and biology research background, trained by Nobel Laureates Jack Szostak and Jennifer Doudna.
Next-generation cancer diagnostics
Sequencing this major class of biomarkers to detect cancer across multiple glycoproteins. From a blood sample.
GlycoSeq™
Decoding the glycome.
We're tackling the last major class of unsequenceable biomolecules–Glycans

GlycoSeq reads glycan patterns across multiple proteins to build richer, multi-marker cancer signatures.
Machine learning uncovers disease.
TECHNOLOGY
We convert identified features into fully resolved structures, then match these to thousands of known signatures of disease.
CEOChemistry and biology research background, trained by Nobel Laureates Jack Szostak and Jennifer Doudna.
COOOperations, fundraising, and long-term project management background.
CTOBiomolecular engineering research and quantitative product strategy background.
Join a focused team building a new diagnostic platform.
View opportunitiesLead experiments and translate our roadmap into lab practice.
Run experiments alongside senior scientists.
Hands-on research for early undergraduates.
Research, investment, careers, or collaboration.
contact@oxumglyco.com